Bollard Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.27M Buy
38,354
+601
+2% +$53.6K 0.1% 73
2025
Q4
$2.98M Sell
37,753
-6,531
-15% -$512K 0.07% 73
2025
Q3
$3.54M Buy
44,284
+2,212
+5% +$189K 0.08% 73
2025
Q2
$3.82M Buy
42,072
+1,875
+5% +$171K 0.09% 70
2025
Q1
$3.77M Buy
40,197
+196
+0.5% +$17.6K 0.1% 63
2024
Q4
$3.64M Sell
40,001
-17,476
-30% -$1.67M 0.1% 61
2024
Q3
$5.97M Buy
57,477
+253
+0.4% +$25.8K 0.16% 51
2024
Q2
$5.55M Buy
57,224
+770
+1% +$71K 0.16% 50
2024
Q1
$5.08M Buy
56,454
+1,291
+2% +$109K 0.15% 51
2023
Q4
$4.4M Buy
55,163
+315
+0.6% +$23.7K 0.15% 54
2023
Q3
$3.9M Sell
54,848
-10,392
-16% -$777K 0.14% 59
2023
Q2
$5.03M Buy
65,240
+302
+0.5% +$23.4K 0.17% 64
2023
Q1
$4.88M Sell
64,938
-7,711
-11% -$573K 0.18% 64
2022
Q4
$5.72M Sell
72,649
-2,279
-3% -$171K 0.22% 59
2022
Q3
$5.26M Buy
74,928
+342
+0.5% +$26.8K 0.22% 58
2022
Q2
$5.98M Buy
74,586
+352
+0.5% +$27.5K 0.24% 59
2022
Q1
$5.63M Buy
74,234
+3,328
+5% +$264K 0.18% 70
2021
Q4
$6.05M Buy
70,906
+314
+0.4% +$24.5K 0.19% 70
2021
Q3
$5.33M Buy
70,592
+425
+0.6% +$33.7K 0.17% 75
2021
Q2
$5.71M Sell
70,167
-692
-1% -$56.6K 0.18% 71
2021
Q1
$5.59M Buy
70,859
+102
+0.1% +$8K 0.2% 63
2020
Q4
$6.05M Sell
70,757
-3,409
-5% -$282K 0.23% 55
2020
Q3
$5.72M Buy
74,166
+102
+0.1% +$7.78K 0.21% 59
2020
Q2
$5.43M Sell
74,064
-33,113
-31% -$2.35M 0.21% 59
2020
Q1
$7.11M Buy
107,177
+6,066
+6% +$428K 0.32% 48
2019
Q4
$6.96M Buy
101,111
+111
+0.1% +$7.57K 0.23% 63
2019
Q3
$7.42M Buy
101,000
+565
+0.6% +$41K 0.26% 58
2019
Q2
$7.2M Buy
100,435
+7,137
+8% +$507K 0.25% 61
2019
Q1
$6.39M Buy
93,298
+22,752
+32% +$1.47M 0.24% 55
2018
Q4
$4.2M Buy
70,546
+5,056
+8% +$316K 0.19% 64
2018
Q3
$4.38M Buy
65,490
+7,470
+13% +$498K 0.18% 69
2018
Q2
$3.76M Buy
58,020
+3,275
+6% +$214K 0.17% 67
2018
Q1
$3.92M Buy
54,745
+1,905
+4% +$137K 0.2% 65
2017
Q4
$3.99M Buy
52,840
+1,282
+2% +$93.6K 0.19% 59
2017
Q3
$3.76M Buy
51,558
+2,276
+5% +$164K 0.2% 63
2017
Q2
$3.65M Buy
49,282
+668
+1% +$49.6K 0.2% 68
2017
Q1
$3.56M Buy
48,614
+5,239
+12% +$367K 0.2% 68
2016
Q4
$2.84M Buy
43,375
+860
+2% +$59K 0.19% 73
2016
Q3
$3.15M Buy
42,515
+216
+0.5% +$16K 0.2% 68
2016
Q2
$3.1M Buy
42,299
+220
+0.5% +$15.7K 0.21% 59
2016
Q1
$2.97M Buy
42,079
+237
+0.6% +$15.8K 0.24% 59
2015
Q4
$2.79M Buy
41,842
+242
+0.6% +$16.1K 0.23% 57
2015
Q3
$2.64M Sell
41,600
-841
-2% -$54.9K 0.22% 63
2015
Q2
$2.78M Buy
42,441
+230
+0.5% +$15.6K 0.21% 67
2015
Q1
$2.93M Buy
42,211
+3,049
+8% +$211K 0.22% 65
2014
Q4
$2.71M Buy
39,162
+2,258
+6% +$152K 0.24% 62
2014
Q3
$2.41M Buy
36,904
+1,517
+4% +$100K 0.23% 69
2014
Q2
$2.41M Buy
35,387
+11,295
+47% +$757K 0.23% 64
2014
Q1
$1.56M Buy
24,092
+11,900
+98% +$750K 0.16% 81
2013
Q4
$795K Buy
12,192
+9,992
+454% +$640K 0.09% 119
2013
Q3
$130K Buy
+2,200
New +$130K 0.02% 193

Other funds holding CL

Bollard Group's CL Position: Q1 2026 in Review

Bollard Group increased its Colgate-Palmolive (CL) stake by 1.6% in Q1 2026, buying an estimated $53.6K and bringing the position to 38,354 shares worth $3.27M. The position accounts for 0.1% of the portfolio, ranked #73.

Bollard Group first reported a position in CL in Q3 2013 and has held it in 51 quarters since. The position peaked at $7.42M in Q3 2019. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Bollard Group held 38,354 shares of Colgate-Palmolive worth $3.27M as of Q1 2026.
  • Bollard Group bought 601 Colgate-Palmolive shares in Q1 2026, an estimated $53.6K.
  • Colgate-Palmolive made up 0.1% of Bollard Group's portfolio in Q1 2026, its #73 holding.
  • Bollard Group first reported a position in Colgate-Palmolive in Q3 2013 and has held it in 51 quarters since.
  • Bollard Group's Colgate-Palmolive position peaked at $7.42M in Q3 2019.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Bollard Group's 13F filing for Q1 2026, filed 14 May 2026.